CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[FDA OKs Ropeginterferon Alfa for Essential Thrombocytopenia]]>

Phase 3

Read the original article

Published by Cancer Network on August 31, 2026 12:38 PM

Read Original